-+ 0.00%
-+ 0.00%
-+ 0.00%

Stoke Therapeutics grants CSO McCauley options for 225,000 shares at $29.91 each

PUBT·07/16/2026 20:01:19
Listen to the news
Stoke Therapeutics grants CSO McCauley options for 225,000 shares at $29.91 each
  • Stoke Therapeutics granted stock options on July 15, 2026 to new hires, led by newly appointed Chief Scientific Officer Thomas McCauley.
  • McCauley received options for 225,000 shares at an exercise price of $29.91, matching the July 15 close.
  • Seven additional employees received options for 83,070 shares at $29.91.
  • Awards vest over four years: 25% after one year, then monthly over the next 36 months; options run for 10 years.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Stoke Therapeutics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202607161601BIZWIRE_USPR_____20260716_BW006460) on July 16, 2026, and is solely responsible for the information contained therein.